Influencing Next-Generation Oncologic Outcomes Through Rapid Integration of Functional Precision Medicine (NOORI): A Feasibility Study of SmartMatch in Rare Gynecologic Cancers

Summary

This study is being done to determine how easy it is to use standard of care (SOC) surgical resections or biopsy for SmartMatch analysis to determine treatment options in advanced gynecological malignancies.

Eligibility

Inclusion Criteria:

* Age ≥ 18 years
* Histologically confirmed rare gynecologic malignancy, including but not limited to those listed
* Metastatic or unresectable disease, OR disease for which additional systemic therapy is indicated
* Fresh tumor tissue available from a SOC surgical procedure or biopsy that in the judgment of the treating team will yield adequate viable tumor for SmartMatch analysis
* Eastern Cooperative Oncology Group (ECOG) performance status 0-2
* Adequate organ function to receive systemic therapy as determined by the treating oncologist (protocol does not specify thresholds because therapy is not mandated)
* Ability to understand and willingness to sign informed consent
* Willingness to allow data abstraction from the electronic health record for study endpoints

Exclusion Criteria:

* Lack of tumor tissue suitable for SmartMatch analysis
* Purely borderline tumors or benign ovarian/uterine neoplasms
* Any condition that, in the opinion of the treating oncologist or PI, would interfere with receiving systemic therapy
* Inability to provide informed consent or comply with study procedures

Conditions4

Locations1 site

Find trials near these locations

Browse More Trials